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Identifying microRNA (miRNA)-regulated genes is
key to understanding miRNA function. However,
many miRNA recognition elements (MREs) do not
follow canonical ‘‘seed’’ base-pairing rules, making
identification of bona fide targets challenging. Here,
we apply an unbiased sequencing-based systems
approach to characterize miR-522, a member of the
oncogenic primate-specific chromosome 19 miRNA
cluster, highly expressed in poorly differentiated can-
cers. To identify miRNA targets, we sequenced full-
length transcripts captured by a biotinylated miRNA
mimic. Within these targets, mostly noncanonical
MREswere identifiedby sequencingRNase-resistant
fragments. miR-522 overexpression reduced mRNA,
protein levels, and luciferase activity of >70% of a
random list of candidate target genes andMREs. Bio-
informatic analysis suggested thatmiR-522 regulates
cell proliferation, detachment, migration, and epithe-
lial-mesenchymal transition. miR-522 induces G1
cell-cycle arrest and causes cells to detach without
anoikis, become invasive, and expressmesenchymal
genes. Thus, ourmethod provides a simple but effec-
tive technique for identifyingmiRNA-regulated genes
and biological function.INTRODUCTION
Identification of microRNA (miRNA) target genes and the specific
sequences they bind (miRNA recognition elements [MREs]) is
important for understanding miRNA function (Bartel, 2009).
Target prediction algorithms and experimental methods can be
combined to identify candidate miRNA-regulated genes (Bartel,
2009; Thomas et al., 2010). However, even the best methods
leave room for improvement. Target prediction algorithms areCelmostly based on a set of canonical rules for miRNA-mRNA
interactions, in the 30 UTR of the mRNA, mediated by comple-
mentarity to the seed region (nucleotides 2–8 of the miRNA).
However, increasing evidence suggests that noncanonical
MREs, involving bulges and G:U wobbles, pairing outside the
seed and even ‘‘seedless’’ interactions, in the 30 UTR as well
as CDS, are not uncommon (Lal et al., 2009; Tay et al., 2008;
Xia et al., 2012). The canonical rules may apply only to some
miRNAs and to only a quarter of all miRNA-mRNA interactions
overall (Helwak et al., 2013).
Biochemical isolation of target mRNAs bound to AGO and the
RNA-induced silencing complex has improved MRE identifica-
tion. AGO pull-down, combined with crosslinking and RNase
digestion (high-throughput sequencing of RNA isolated by
crosslinking immunoprecipitation [HITS-CLIP], crosslinking and
immunoprecipitation followed by high-throughput sequencing
[CLIP-Seq], and photoactivatable-ribonucleoside-enhanced
crosslinking and immunoprecipitation [PAR-CLIP]), generates a
global snapshot of miRNA-mRNA interactions (Chi et al., 2009;
Hafner et al., 2010; Loeb et al., 2012; Zisoulis et al., 2010). How-
ever, these methods, even when combined with manipulation of
miRNA expression, may not be adequate for identifying the
mRNAs regulated by a particular miRNA. In fact, they usually
rely on seed-based analysis or predictive algorithms to match
the isolated MRE sequences to miRNAs. Recently, a novel unbi-
ased method of mapping RNA-RNA interactions, termed cross-
linking ligation and sequencing of hybrids (CLASH), was used to
identify miRNA-MRE pairs by ligating bound MREs to their
cognate miRNAs (Helwak et al., 2013). These global miRNA-
binding methods are technically challenging, require large
numbers of cells, and are most effective for identifying highly
expressed miRNAs and their targets. UV crosslinking, which is
central to these methods, is inefficient and can introduce back-
ground. For example, it increases the false discovery rate in
genome-wide studies of RNA-protein interactions (Keene et al.,
2006). Although use of photoactivatable nucleosides, as in
PAR-CLIP, increases the specificity of target identification, it re-
stricts crosslinking to the photoreactive nucleotide, potentially
causing sequence bias (Kishore et al., 2011).l Reports 8, 1225–1239, August 21, 2014 ª2014 The Authors 1225
Figure 1. Identification of miR-522 Targets by Pulldown-Seq and Microarray Analysis
(A) Schematic of the strategy used to identify miR-522 target transcripts, MREs, and function.
(B) Volcano plot of gene enrichment in miR-522 versus control Pulldown-seq data set. Red box denotes genes enriched >2-fold with p < 0.05.
(C) Bubble plot of genes in the red box in (B). Genes significantly downregulated after miR-522 overexpression bymicroarray analysis (FDR < 0.1) are in red, those
not downregulated are in blue, and those not represented on the microarray are in gray. The size of each bubble is proportionate to the extent of downregulation.
Note the higher proportion of red bubbles and larger bubbles with increasing enrichment.
(legend continued on next page)
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Bona fide targets for specific miRNAs can be identified
without bias by isolating mRNAs bound to a transfected miRNA
mimic biotinylated at the 30 end of the active strand (Lal et al.,
2011; Ørom et al., 2008). These transfected miRNA mimics
are incorporated into the miRNA-induced silencing complex
(miRISC) and bind to and downregulate known mRNA targets.
Their association with target mRNAs is not a postlysis artifact,
because they do not pull down miRNA targets when added to
lysed cells (Lal et al., 2011). These pull-downs do not require
crosslinking and can be performed with just a million cells
(20-fold fewer than crosslinking protocols). Typically hun-
dreds to thousands of transcripts are identified as candidate
genes regulated by an individual miRNA. Despite these large
numbers, the method has high specificity (90% in one study;
Lal et al., 2011). However, this method has some shortcomings.
Because it uses mRNA microarrays to identify enriched candi-
date targets, it only identifies mRNAs probed on the array and
does not directly identify MREs. Identifying the key miRNA tar-
gets and its function(s) from the large network of enriched
genes is difficult and relies heavily on gene ontology analysis
of target mRNAs. Here, we sought to improve the identification
of miRNA targets and function by altering the protocol and
subsequent functional analysis to generate a simple, systems-
based method for miRNA target characterization (Figure 1A).
We replaced the microarray with deep sequencing (Pulldown-
seq) and added an RNase step to identify MREs (which we
call IMPACT-seq for identification of MREs by pull-down and
alignment of captive transcripts—sequencing). We also added
analysis of the transcription factors that regulate the target
genes to gene ontology and interactome analysis of both
pulled-down and downregulated genes. These improvements
allowed us to identify rapidly key target genes and biological
functions of a previously uncharacterized primate-specific
miRNA, miR-522.
miR-522 is a member of the chromosome 19 miRNA cluster
(C19MC), a 100 kb primate-restricted region that encodes for
54 tandem miRNAs—the largest miRNA cluster in the hu-
man genome. C19MC is highly expressed in human embryonic
stem cells and poorly differentiated tumors (Li et al., 2009;
Rippe et al., 2010). Members of the cluster, some of which
share a common seed, regulate key stem cell genes implicated
in cancer, including the Wnt pathway and the tumor-suppres-
sor gene CDKN1A (p21Cip1/Waf1; Wu et al., 2010). Thus,
C19MC may be an oncogenic miRNA cluster. However, nothing
is known about the targets or function of miR-522. Here, we
use our new method to discover that miR-522 enhances the
ability of triple negative breast cancer (TNBC) cells to survive
detachment, invade through a membrane, and express mesen-
chymal genes, properties associated with metastasis. At the
same time, it causes cells to arrest at G1/S, reducing cell
proliferation.(D) Cumulative gene expression after miR-522 overexpression, comparing miR-
enrichment (*K-S test p < 0.05; ***p < 0.001).
(E) Cumulative gene expression plot comparing miR-522 targets identified by Pulld
(***p < 0.001).
See also Figure S1.
CelRESULTS
miR-522 Is Overexpressed in TNBCs and Other
Aggressive Cancers, and Its Amplification Is Associated
with Poor Prognosis
Four C19MC miRNAs (miR-517c, miR-519a, miR-521, and miR-
522) are overexpressed in TNBCs (Enerly et al., 2011), but only
miR-522 is consistently significantly overexpressed in poorly
differentiated estrogen receptor (ER)-negative or TNBC, relative
to more differentiated ER+ and luminal breast cancers or normal
breast tissue, in four additional independent data sets (Biagioni
et al., 2012; Buffa et al., 2011; Lowery et al., 2009; Cancer
Genome Atlas Network, 2012; Figure S1A). The difference in
miR-522 expression between luminal breast cancer and TNBCs
was confirmed using ten representative cell lines (Figure S1B).
Identification of miR-522 Target Transcripts by
Pulldown-Seq
To identify genes regulated by miR-522, we used the human
TNBC cell line MDA-MB-468, which expresses miR-522, as a
model system. The RNAs pulled down with biotinylated miR-
522 and cel-miR-67 (control miRNA) were compared by RNA
sequencing (Pulldown-seq). We obtained 550 and 403 million
uniquely aligned bases from two biological replicate experi-
ments, each sequenced in duplicate, from miR-522 and control
miRNA samples, respectively, of which about 75% aligned to
annotated transcripts. miR-522 target fold enrichment (FE) and
p values (p) compared to control miRNA, calculated based on
the fragments per kilobase of exon per million fragments map-
ped (FPKM) of each data set, were depicted in a volcano plot
(Figure 1B). Technical validation of 12 randomly selected genes
by quantitative RT-PCR (qRT-PCR) confirmed the accuracy of
the sequencing data (R2 = 0.89; Figure S1C). A total of 547
RNAs (mostly mRNAs [85%] but also novel transcripts, pseudo-
genes, large intergenic noncoding RNAs [lincRNAs], and miR-
NAs) satisfied the cutoff conditions of FE > 2 and p < 0.05
(Figure S1D; Table S1). Depletion of cell lysates with pan-AGO
antibody and qRT-PCR analysis of three captured miR-522
target mRNAs showed that Pulldown-seq mostly identified
AGO-associated target mRNAs, because the AGO antibody
depleted 70%–80% of these targets (Figure S1E).
The mRNA of most bona fide miRNA targets is diminished by
miRNA overexpression (Bartel, 2009; Lal et al., 2011). Therefore,
to assess the quality of mRNA target identification, Illumina
beadchip expression microarrays were used to identify genes
downregulated by miR-522 overexpression. The accuracy of
the microarray data was confirmed by qRT-PCR analysis of 12
randomly selected genes (R2 = 0.76; Figure S1F). Of the 547
miR-522 targets, 428 were probed on the microarray and 255
(60%) had significantly downregulated mRNA (false discovery
rate [FDR] < 0.1; Figure 1C; Table S1). Cumulative frequency522 targets identified by Pulldown-seq using three different cutoffs. FE, fold
own-seq (FE > 2; p < 0.05) with those predicted by target prediction algorithms
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plots compared mRNA changes after miR-522 overexpression
of genes enriched in the pull-down, defined by different cutoffs,
with changes in all genes or algorithm-predicted target genes
(Figures 1D and 1E). The decrease in mRNA of the 47 genes
selected from the pull-down data using a FDR of <0.1 (40 on
the microarray) was similar to the decrease in gene expression
of the 197 genes (130 on the microarray) chosen using a cutoff
of FE > 4 and p < 0.01. The less stringent cutoff (FE > 2; p <
0.05) used to define the 547 miR-522 target genes also highly
enriched for downregulated mRNAs, outperforming all five algo-
rithm-predicted gene lists (TargetScan, miRanda, PITA, DIANA,
and RNA22). Of the algorithms, TargetScan-predicted targets
were the most significantly downregulated after miR-522 over-
expression (Figure 1E). Pulldown-seq significantly outperformed
TargetScan, even though it identified more targets (428 versus
331; p < 0.001). Of the 547 candidate target genes, only 53 (47
on the array) were also predicted by TargetScan.
Most miR-522-Associated Genes Had Reduced mRNA
and Protein after miR-522 Overexpression
To evaluate the specificity of the pull-down, a random list of 30
genes representing the full range of FE and p values of identified
miR-522 targets was chosen. The effect of miR-522 overexpres-
sion on mRNA and protein levels was assessed by microarray
and immunoblot densitometry, respectively (Figure 2; Table
S1). Eighty-three percent (25 of 30) showed significantly reduced
mRNA, and 73% (22 of 30) had significantly reduced protein.
Thus, Pulldown-seq is very specific for identifying miRNA tar-
gets. To test whether endogenous miR-522 suppresses expres-
sion of putative Pulldown-seq target genes, we used qRT-PCR
to quantify selected target gene mRNAs in cells transfected
with anti-miR-522 or a control hairpin. Antagonizing endogenous
miR-522 significantly increased three of four miR-522 target
mRNAs (BANF1, DHFR, and TIMP3), but not negative control
BRCA1. Thus, some of the target genes are regulated by endog-
enous levels of miR-522 (Figure S1G).
Identification of miR-522 Target MREs by IMPACT-Seq
MRE prediction algorithms work best for evolutionarily con-
served miRNAs and target sequences. To identify MREs of pri-
mate-specific miRNAs, like miR-522, alternate approaches are
especially needed. We therefore modified Pulldown-seq to iden-
tify MREs, which we call IMPACT-seq. IMPACT-seq requires no
crosslinking and only mild RNase T1 treatment of bead-captured
miRISCs. cel-miR-67 miRNA was again used as a control to
reduce background from RNAs bound nonspecifically to the
beads or miRISC. We sequenced and mapped 3.1 and 1.6
million reads uniquely to the genome for control miRNA and
miR-522, respectively. Importantly, approximately 65% of all
reads had a guanine residue at the 30 end, indicating that most
reads were generated by RNase T1 cleavage. Notably, only
0.7% of the 100,145 reads mapped to other miRNAs (Table
S2), indicating that almost all of the sequences captured by
IMPACT-seq were associated with miR-522. To identify miR-
522 MREs in each sample, we used CLIPper (https://github.
com/YeoLab/clipper/), which defines peaks in CLIP experi-
ments. miR-522 peaks were compared to control miRNA peaks
and the significance of each potential MRE computed based on1228 Cell Reports 8, 1225–1239, August 21, 2014 ª2014 The Authora Poisson distribution. The number of normalized reads was also
computed for each sample (Table S2). With FE > 2 and p < 0.05
cutoffs, we identified 4,848 peaks in 2,966 transcripts with at
least five reads in the miR-522 sample as possible MREs.
IMPACT-seq generated sharp, distinct peaks, making it rela-
tively easy to identify MREs with CLIPper or manually using a
genome browser (Figure 3A). A large proportion of the RNase-
protected sequences (64%) were between 20 and 40 bp,
enabling us to identify complementary sequences easily (Fig-
ure 3B). Ninety-six percent of miR-522 candidate MREs were
located in protein-coding transcripts—53% in the 30 UTR, 30%
in the CDS, and 13% in the 50 UTR (Figure 3C; Table S2). The re-
maining sequences aligned to lincRNAs, miRNAs, pseudogenes,
and antisense RNAs. Of the 2,467 30 UTR MREs, only 111 were
predicted by PITA, miRanda, and/or TargetScan (Tables S1
and S2).
IMPACT-seq miR-522 targets were also significantly downre-
gulated by miR-522 overexpression but to a lesser extent than
Pulldown-seq targets (Figure 3D). The extent of downregulation
was similar to the miRanda gene set, but not as good as the Tar-
getScan-predicted genes. Of the 4,848 IMPACT-seq MREs, 743
were in 56% (306 of 547) of Pulldown-seq transcripts. The 275
genes identified by both Pulldown-seq and IMPACT-seq per-
formed comparably to the Pulldown-seq target set (Figure 3D).
The lack of MREs for 44% of Pulldown-seq mRNAs and the
less-striking downregulation of IMPACT-seq genes suggest
that IMPACT-seq could be improved.
To analyze the regions of miR-522 complementarity in these
sequences, the GLAM2 tool in the MEME suite of motif-based
sequence analysis tools (which allows for gaps or bulges) was
used to discover motif(s) (Frith et al., 2008). Reasoning that
MREs between 25 and 35 bases in length would contain only sin-
gle-miR-522-binding sites, we limited analysis to these 1,887 se-
quences. We found that 1,639 sequences contained an enriched
motif partially complementary to residues 13–20 of miR-522
(score: 9,426), and 1,753 contained an enriched motif partially
complementary to residues 2–9 in the seed region of miR-522
(score: 9,113). One hundred scrambled versions of the RNase-
protected sequences had a significantly lower GLAM2 score of
2,576 ± 1,245 (Figure 3E). Most sequences contained motifs
partially complementary to both the 50 and 30 ends of miR-522.
Thus, miR-522 appears to belong to a recently described class
of miRNAs, whose MREs are imperfectly complementary to
both miRNA ends (Helwak et al., 2013). Fifty-nine percent of
all transcripts containing these GLAM2 motifs were significantly
downregulated after miR-522 overexpression. Their cumulative
frequency plots were also statistically indistinguishable, sup-
porting our conclusion that miR-522 MREs contain imperfect
complementary matches at both ends (Figure 3D; data not
shown).
To test the accuracy of IMPACT-seq MRE identification, we
cloned a random set of 30 putativeMREs (representing the range
of read number and FE scores, most of which had a GLAM2
motif) into luciferase reporter plasmids and performed reporter
assays (Table S3). Only four were predicted targets and five
(17%) had a perfect seed match. Four sequences of similar
length that were not identified as MREs, but were encoded in
MRE-containing genes, were used as controls. Twenty-five ofs
Figure 2. Most miR-522 Pulldown-Seq Targets Have Reduced mRNA and Protein after miR-522 Overexpression
A random set of 30 miR-522 Pulldown-seq targets was analyzed for changes in mRNA and protein expression after miR-522 overexpression.
(A) Microarray analysis of cubic spline-normalized mRNA expression after miR-522 overexpression, compared to control miRNA expression, where + indicates
FDR < 0.1.
(B and C) Representative immunoblots (B) and mean ± SD signal intensity relative to b-actin of three independent experiments (C), comparing cells transfected
with miR-522 and control miRNA (*p < 0.05, compared to control).the candidate MREs (83%) reduced luciferase activity (Fig-
ure 3F), suggesting that IMPACT-seq is very specific. To confirm
that these genes were indeed direct targets of miR-522, we
cloned the full-length 30 UTRs of eight genes with 30 UTR
MREs validated in Figure 3F and performed luciferase reporter
assays (Figure 3G). Only one of these did not reduce luciferaseCelactivity upon miR-522 overexpression, indicating that most of
these MREs function within the endogenous 30 UTR.
miR-522 Target Functional Analysis
To uncover the function of miR-522, we combined several bioin-
formatics tools to analyze the Pulldown-seq data set. First, wel Reports 8, 1225–1239, August 21, 2014 ª2014 The Authors 1229
(legend on next page)
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used TRANSFAC, a well-curated knowledge base of eukaryotic
transcription factors (Matys et al., 2006), to search for overrepre-
sented transcription factors predicted to bind to the promoter
regions upstream of miR-522 target genes. Binding sites for
four transcription factors, ELK1, E2F, TEAD2, and PAX3, which
are all expressed in MDA-MB-468, were significantly enriched
in the promoters of the 547 Pulldown-seq genes (Figure 4A).
ELK1 and E2F3 were also identified as miR-522 target genes
that were enriched 17- and 2.8-fold in the pull-down, respec-
tively. The mRNA and protein levels of both were significantly
downregulated by miR-522 overexpression (Table S1; Figure 2).
ELK1 and PAX3 both enhance the epithelial state. ELK1-regu-
lated genes are downregulated during transforming growth
factor b (TGF-b)-induced epithelial mesenchymal transition
(EMT) (Venkov et al., 2011), whereas PAX3 expression enhances
mesenchymal epithelial transition (MET) (Wiggan et al., 2002). Of
note, TEAD2 transcriptionally activates PAX3 (Milewski et al.,
2004). This analysis suggests that miR-522 might foster EMT.
E2F transcription factors promote G1/S progression in the cell
cycle (Fan and Bertino, 1997), suggesting that miR-522 might
inhibit progression at this phase of the cell cycle.
miRNAs can target multiple genes that participate in common
pathways (Lal et al., 2009, 2011). We therefore next used ingenu-
ity pathway analysis (IPA), which curates biological interactions
and function (Ingenuity Systems; http://www.ingenuity.com), to
identify all directly related miR-522 target genes (Figure S2).
This interactome of 221 genes was then analyzed using IPA to
identify the top network-associated functions (Figure 4B). These
included cellular movement and morphology (functional compo-
nents of EMT), embryonic development (of which EMT is an
essential component), as well as cell cycle, corroborating the
TRANSFAC analysis. To include possible indirect functional
effects of miR-522, we next identified common molecular func-
tions overrepresented in both the Pulldown-seq interactome
and set of 205 directly connected genes whose mRNAs were
significantly downregulated after miR-522 overexpression (p <
0.0001 and fold change > 1.5; Table S4). The p values for each
common overrepresented molecular function were displayed
in a bubble plot, where the number of miR-522 target genes
identified by Pulldown-seq for each function is proportional to
the bubble size (Figure 4C). Themost significantly enriched func-
tions, for which more than ten target genes were annotated, fell
into four large functional categories: proliferation, apoptosis, cellFigure 3. Identification of miR-522 MREs by IMPACT-Seq
(A) Sequencing reads of four miR-522 targets and MREs. Numbers in Pulldown-s
0–50 reads). IMPACT-seq-identified MREs are indicated below in blue; two of th
(B) Lengths of sequences containing identified miR-522 MREs. Most MRE-conta
(C) Distribution of miR-522 MREs among RNA classes. The majority of predicted
(D) Cumulative gene expression plot comparing miR-522 targets identified by IM
gorithms (***K-S test p < 0.001).
(E) GLAM2 gapped motif analysis of 1,887 MREs between 25 and 35 nt shows en
match in 1,753 MREs (left box, seed sequence underlined). GLAM2 analysis for 1
significantly lower mean score ± SD (representative motif shown in the right box
(F) Dual luciferase assay of 30 randomly selected MREs. RC indicates the miR-52
control sequences not bound by miR-522, and PC2 denotes the empty vector. Tw
independent experiments (*p < 0.05 compared to control).
(G) Dual luciferase assay of eight full-length 30 UTRs with verified miR-522 MRE
regulated by miR-522. Mean ± SD of three independent experiments (*p < 0.05 c
Celcycle, and cell morphology/migration/transformation. The latter
two categories also stood out in both the TRANSFAC and IPA
analyses. Based on these bioinformatics, we hypothesized that
miR-522 might regulate G1/S cell cycle progression, cell trans-
formation and survival, cell motility, and EMT, which we next
investigated in MDA-MB-468 TNBC cells.
miR-522 Overexpression Induces Mesenchymal
Properties
Loss of cellular adhesion is an easily detectable phenotype that
involves changes in cell morphology, movement, and cytoskel-
etal organization and is an important step in EMT (Yang and
Weinberg, 2008). In tissue culture, most MDA-MB-468 cells are
adherent, but some detach and remain viable. We first assessed
by TaqMan PCR whether miR-522 levels might be different in
adherent versus nonadherent cells. miR-522 was expressed at
significantly higher levels in nonadherent than adherent cells,
but another C19MC miRNA (miR-519a), miR-16, and let-7a
were expressed similarly (Figure 5A). Overexpression of miR-
522 decreased the number of live adherent cells and increased
the number of live cells in suspension (Figure 5B). To assess
whether miR-522 expression was responsible for loss of adhe-
sivity, we collected suspension cells that were transfected
48 hr previously with either control miRNA or miR-522 and re-
transfected an equal number of each with control miRNA, miR-
522, or anti-miR-522. Only cells transfected with anti-miR-522
formed adherent colonies (Figure 5C). Thus, miR-522 promotes
detachment and viability of detached cells.
We next investigated whether miR-522 promotes EMT.
Changes in important mesenchymal gene (ZEB2, TWIST1,
FOXC2, SNAI1, SNAI2, and VIM) transcripts were assessed by
qRT-PCR in adherent and nonadherent cells 3 and 5 days after
miR-522 or control miRNA transfection (Figures 5D and 5E).
Expression of all six genes strongly and progressively increased
in both cell populations but most dramatically in nonadherent
cells. However, epithelial genes encoding E-cadherin (CDH1)
or the cytokeratins (KRT14, KRT18, and KRT19) did not signifi-
cantly change (Figure S3A). These results are consistent with
the notion that poorly differentiated cancer cells exhibit plasticity
in epithelial and mesenchymal properties and can simulta-
neously show features of both states (Granit et al., 2013). Over-
expression of miR-522, and to a lesser extent miR-517c, but not
the other two C19MC miRNAs abundant in TNBCs (Enerly et al.,eq plots indicate mean FPKM (scale: Pulldown-seq 0–100 reads, IMPACT-seq
ese also predicted by Miranda are shown in red.
ining sequences were between 20 and 40 nt.
MREs were in the 30 UTR of mRNAs.
PACT-seq and/or Pulldown-seq with those predicted by target prediction al-
richment of a 30 supplementary motif in 1,639 MREs and a noncanonical seed
00 iterations of scrambled sequences of the same MREs resulted in motifs with
).
2 reverse complement sequence used as positive control, C indicates negative
enty-five of 30 MREs were functional by luciferase assay. Mean ± SD of three
s in (F), using the same positive and negative controls. Seven of eight were
ompared to control).
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Figure 4. Bioinformatics Analysis of miR-522 Target Genes
(A) Promoter regions of miR-522 target genes that were enriched for binding sites of four transcription factors by TRANSFAC analysis.
(B) Top enriched functions of directly associated miRNA-522 targets by IPA. Score: log10(p value). EMT-related functions are indicated in red.
(C) Bubble plot of the IPAmolecular function p values of directly associated miR-522 targets plotted against interactome genes that were downregulated by miR-
522 overexpression (IPA p < 0.0001; FC > 1.5). The size of each bubble is proportional to the number of miR-522 target genes assigned to that molecular function.
Bubbles are selectively annotated based on low p values and large size and annotated by function: cell cycle (black), proliferation (blue), cell death (green), cancer
(purple), EMT-related (cell morphology, movement, transformation, and differentiation: red), and others (gray).
See also Figure S2.
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2011), induced EMT marker expression. These miRNAs func-
tioned differently, even though they have strikingly similar se-
quences (Figure S3B).
EMT is linked to cancer stem cells, invasion, andmetastasis. A
small, but significant, increase in the stem/early progenitor cell
genes, CD44 and CD133, was also seen (Figure S3A). CD44+/
CD24low/ expression enriches for cancer stem cells. Although
most MDA-MB-468 cells are already CD44+, miR-522 overex-
pression reduced CD24 levels (Figures S3C and S3D). Both tran-
sient and stable miR-522 overexpression significantly increased
migration through a membrane by 4- to 5-fold compared to con-
trol cells. More cells migrated and adhered to the membrane or
survived in suspension in the lower chamber (Figures 5F–5I and
S3E). Thus, miR-522 overexpression promotes important EMT
hallmarks.
miR-522 Overexpression Causes G1/S Arrest
We next used propidium iodide staining to examine the effect of
miR-522 on the cell-cycle profile of MDA-MB-468 and HCC1937
TNBC cells. miR-522 overexpression significantly increased the
number of cells in the G1 phase and correspondingly decreased
cells in S and G2/M, compared to control miRNA (Figures 5J,
5K, S3F, and S3G). These results confirm the bioinformatics
analysis.
Target Gene Knockdown Partially Recapitulates
miR-522 Overexpression Phenotype
To test the importance of individual target genes, we chose for
further study 21 genes in the Pulldown-seq data set that function
in adhesion (matrix metalloproteinase inhibitor TIMP3, focal
adhesion regulator ZFYVE21, cell-matrix regulator YWHAZ,
developmental transcription factor and cell adhesion regulator
HOXA1, and epithelial cell adhesion regulator PFN1); EMT
(genes whose knockdown induces EMT—SPSB1, ADAM17
[Liu et al., 2009], FOXA1 [Song et al., 2010], and DEDD2
[Lv et al., 2012]—or which repress TGF-b signaling—FKBP1A,
TGIF1, TGIF2, and ELK1); or cancer or stem cell biology (tumor
suppressors FOXP1 and DNAJC25, breast cancer-amplified tu-
mor gene TPD52, cycling membrane protein ERGIC1, polycomb
group genes BMI1 and RNF2, Ccr4-NOT deadenylase subunit
CNOT7, and antifolate drug target DHFR). We first asked
whether knockdown of these genes individually recapitulated
miR-522’s ability to promote detachment without anoikis. Each
of these genes was knocked down at least 3-fold, except for
TGIF1, whose expression was reduced 2-fold (Figure S4).
Knockdown of 10 of the 21 genes, including all five adhesion-
related genes and half of the EMT-related genes, significantly
decreased the number of attached viable cells 3 days later (Fig-
ure 6A). However, knockdown of only three of these (ZFYVE21,
TIMP3, and SPSB1) also increased the number of live cells in
suspension (Figure 6B). Knockdown of four other genes
(FOXA1, DEDD2, TPD52, and BMI1) only increased the number
of viable nonadherent cells.
Next, we examined by qRT-PCR whether individual knock-
down of any of the 21 genes enhanced expression of the
mesenchymal transcription factors ZEB2, FOXC2, and SNAI2
upregulated by miR-522 (Figure 6C). Knocking down TIMP3,
PFN1, FOXA1, TGIF2, SPSB1, or BMI1 upregulated all threeCeltranscription factor mRNAs 5 days later, although less potently
than miR-522 overexpression. These data suggest that miR-
522 regulates invasivity and mesenchymal gene expression by
suppressing the expression of multiple genes identified by Pull-
down-seq.
DISCUSSION
IdentifyingmiRNA targets and function is challenging, requiring a
lot of trial and error (Thomas et al., 2010). This is especially true of
nonconserved miRNAs and miRNAs that recognize their targets
by noncanonical binding. Here, we describe a relatively straight-
forward systems-based strategy for miRNA target gene identifi-
cation and functional characterization. We used it to identify
miR-522 target genes, MREs, and function, directly and readily,
with a high degree of specificity. Although identified MREs did
not follow canonical rules, most target genes had reduced
mRNA and protein levels when miR-522 was overexpressed,
and most identified MREs tested were active by luciferase assay
(Figure 7A). The method is simple and can be performed with
only a million cells. Other advantages include freedom from as-
sumptions about target recognition rules, reduced sequence
biases from crosslinking, direct genome-wide identification of
regulated mRNAs and MREs, and the ability to identify noncod-
ing transcripts as miRNA targets. Functional miRNAs are associ-
ated with all four AGO homologs (Hafner et al., 2010; Su et al.,
2009). Our method identifies miRNA targets and MREs, regard-
less of which AGO protein(s) are involved. Combining bio-
tinylatedmiRNA pull-downwith AGO immunoprecipitation might
improve target identification and could be used to investigate
whether individual AGOs obey distinct binding rules.
We added TRANSFAC promoter analysis to more commonly
used bioinformatics tools (interactome and gene ontology func-
tional analysis) to analyze both pulled-down and downregulated
genes to facilitate the tricky task of identifying the biological
function of a previously unstudied miRNA. This bioinformatics
work flow led to robust predictions of miR-522 function that
directed experimental efforts into fruitful investigations and
avoided unproductive searching. This streamlined approach
should be useful for uncovering the hidden meaning of large
genome-wide data sets.
Recent studies have suggested that individual miRNAs differ
in how they recognize their targets. miR-522 recognizes its
mRNA targets largely by binding to both an imperfect seed
match and a 30 supplementary motif. In fact, globally noncanon-
ical binding may be more prevalent than canonical seed pairing
(Loeb et al., 2012; Xia et al., 2012). Seed-only interactions were
found in fewer than one in five endogenous miRNA-MRE pairs
identified by CLASH (Helwak et al., 2013). The experimentally
verified miR-522 MREs were located in the CDS and 30 and 50
UTRs of target mRNAs, corroborating previous studies that
MREs occur outside the 30 UTR (Lal et al., 2011; Tay et al.,
2008). Although the 30 UTR was overrepresented and was
where most (56%) MREs were located, this is only a modest
overrepresentation, because 30 UTRs make up 43% of RefSeq
sequences. The PAR-CLIP data set also reported moderate
genome-wide overrepresentation of MREs in the 30 UTR (Hafner
et al., 2010).l Reports 8, 1225–1239, August 21, 2014 ª2014 The Authors 1233
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The cutoffs chosen to define targets are somewhat arbitrary.
Increasing the stringency reduces false positives but also re-
duces the sensitivity for identifying bona fide targets. For
example, changing the fold enrichment cutoff in the pull-down
from 2 to 4 significantly improved the cumulative gene expres-
sion plot but at the cost of dramatically reducing the number of
candidate targets by about a third. However, the most important
targets, those most downregulated by miR-522, may be more
enriched in the pull-down (Figure 1D). With our current cutoffs,
we identified more potential miR-522 targets with IMPACT-seq
than with Pulldown-seq. This apparent discrepancy can be ex-
plained by the fact that IMPACT-seq looks at a much-smaller
sequence window. If a transcript contains MREs for both control
miRNA and miR-522 in different locations, Pulldown-seq will not
identify this transcript as a target unless it is pulled down with
different efficiencies (1,704 transcripts have at least one MRE
in both control and miR-522). However, we identified MREs for
more than half of the miR-522 target transcripts, an impressive
statistic considering that the data sets were generated from
distinct experiments using two different sequencing platforms.
To improve the overlap of regulated mRNAs and MRE-contain-
ing transcripts, the stringency of Pulldown-seq cutoffs could
be relaxed and/or the sequencing coverage of IMPACT-seq
could be improved. With our current method and cutoffs, we
view these two methods of identifying miRNA targets as
complementary.
miR-522 caused G1 cell-cycle arrest and loss of adhesion
without anoikis and induced mesenchymal genes and proper-
ties in a TNBC cell line (Figure 7B). Acquisition of mesenchymal
properties is thought to promote cancer progression and
metastasis, especially in breast cancer (Yang and Weinberg,
2008). Although miR-522 induced mesenchymal genes and
mesenchymal properties, it did not downregulate epithelial
gene expression in this cell line. Breast cancer circulating tumor
cells (CTCs), which are thought to be the intermediary between
primary tumor and secondary metastatic cells, highly express
mesenchymal markers even though most primary solid tumors
and their metastases are epithelial (Aktas et al., 2009; Kallergi
et al., 2011). However, breast cancer CTCs, like the miR-522-
overexpressing cells in this study, often coexpress epithelial
and mesenchymal genes. In fact, CTCs in mice implanted
with metastasizing MDA-MB-468 xenographs express bothFigure 5. Overexpression of miR-522 Induces Hallmarks of Epithelial-M
(A) qRT-PCR analysis of miRNA levels in MDA-MB-468 cells showed a higher leve
(**p < 0.01 compared to control).
(B) Trypan blue exclusion cell counts of adherent and nonadherent cells 3 days aft
522-transfected live cells in suspension. Mean ± SD of three independent exper
(C) Nonadherent cells transfectedwith control ormiR-522 as in (B) were retransfec
miR-522 led to adherent colonies (representative photos).
(D and E) qRT-PCR analysis of EMT genes, normalized toGAPDH, in adherent and
miRNA. Note the difference in the scales. Mean ± SD of three independent expe
(F–H) Transwell invasion assay demonstrates that transient miR-522 overexpre
invading cells. (G) Quantification by calcein AM staining. (H) Quantification of inva
of three independent experiments (**p < 0.01 compared to control).
(I) Transwell invasion assay as in (F) but with MDA-MB-468 cells stably infected
(J and K) Cell-cycle analysis of MDA-MB-468 cells transfected with miR-522 o
representative profile. (K) shows mean ± SD of three independent experiments (
See also Figure S3.
Celmesenchymal genes and epithelial E-cadherin (Bonnomet
et al., 2012). Rather than undergoing an EMT, it might be
more accurate to characterize metastasizing cancer cells as
occupying a metastable state between these two fixed lineages.
Expression of miR-522 may turn on this metastatic program to
increase motility, survival, and numbers of CTCs. Supporting
our hypothesis that miR-522 instigates metastasis, miR-522
was more highly expressed in CTCs from patients with TNBC
tumors that are prone to metastasize than in better prognosis
ER+ tumors (Sieuwerts et al., 2011). There is currently no tar-
geted therapy for TNBC, the breast cancer with the worst prog-
nosis. In the future, miR-522 antagonists could be evaluated for
treating TNBC patients, especially for tumors with amplified
C19MC.
Several miRNAs, including miR-200, miR-205, and miR-34,
induce epithelial transition (Lamouille et al., 2013). Some of these
induce this dramatic change in cellular state by suppressing
key transcriptional activators of mesenchymal genes, such as
Snai1 andSnai2, or transcriptional repressors of epithelial genes,
such as Zeb1/Zeb2. More recently, miRNAs, such as miR-9,
miR-22, and miR-661, have been identified that accomplish
the reverse—reduce expression of epithelial genes and induce
mesenchymal programs (Ma et al., 2010; Song et al., 2013; Vet-
ter et al., 2010). miR-22 targets the TET family of methylcytosine
dioxygenases that may globally suppress epithelial gene expres-
sion indirectly by inhibiting demethylation of miR-200 family
promoters, thereby suppressing Zeb expression. Some of the
mesenchymal-promoting miRNAs suppress the expression of
one or two epithelial genes, such as genes encoding E-cadherin
(miR-9) or nectin-1 (miR-661), which help maintain tight junc-
tions. However, modulation of a single target rarely explains
most of a miRNA’s effect. Many miRNAs target multiple tran-
scripts in the same networks or pathways to regulate biological
processes. An apt analogy might be transcription factors, which
regulate many genes; one regulated gene rarely reproduces the
effect of the transcription factor. Thus, miRNAs regulate the
epithelial-mesenchymal transitions most likely by targeting other
genes in the key pathways that contribute to this transition, aswe
found for miR-522. In fact, a miR-200 pull-down (R. Perdiga˜o-
Henriques, F. Petrocca, G. Altschuler, M.P. Thomas, M.T.N.
Le, S.M.T., W.H., and J.L., unpublished data) identified miR-
200 target genes that interact with Zeb transcription factors toesenchymal Transition
l of miR-522 in nonadherent cells. Mean ±SD of three independent experiments
er transfection with miR-522 or control miRNA showed a higher number of miR-
iments (*p < 0.05 compared to control).
tedwith anti-miR-522, control antisensemiRNA, or miR-522. Only antagonizing
nonadherent cells 3 (D) and 5 (E) days after transfectionwithmiR-522 or control
riments (*p < 0.05; **p < 0.01 compared to control).
ssion increases invasion. (F) Representative photos of crystal violet-stained
ded live cells in suspension in the bottom chamber by CellTiter-Glo. Mean ± SD
with pBABE-Hygro or pBABE-Hygro-miR-522.
r control miRNA, showing an increase in cells in the G1 phase. (J) shows a
*p < 0.05 compared to control). PI, propidium iodide.
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Figure 6. Knockdown of Individual Target Genes Partly Recapitulates Effects of mir-522 Overexpression
(A andB)CellTiter-Glowas used to quantify live adherent (A) and nonadherent cells (B) 3 days after small interfering RNA (siRNA) ormiRNA transfection, normalized
to nontargeting siRNA control (siNT). Bars in purple indicate genes whose knockdown both decreased live adherent cells and increased live nonadherent cells.
(C) qRT-PCR analysis of relative EMT gene mRNA in adherent cells 5 days after siRNA or miRNA transfection. Relative mRNA level normalized to GAPDH was
compared to cells transfected with siNT. Knockdown of genes in the red boxes significantly enhanced the expression of all three mesenchymal transcription
factors. Mean ± SD of three independent experiments (*p < 0.05; compared to control).
See also Figure S4.
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Figure 7. Model of miR-522 Functions
(A) Summary of experimental results to validate the specificity
of Pulldown-seq and IMPACT-seq for identifying miR-522
target mRNAs and MREs.
(B) Schematic showing important miR-522 targets and their
biological functions.suppress epithelial genes. The advantage of Pulldown-seq is its
ability to identify without bias bona fide miRNA targets. Our re-
sults suggest that miR-522 targets a large number of transcripts,
of which probably only a subset are biologically important in a
given cell at a particular time. It will be worthwhile to define at
a systems level the genes regulated by the EMT- andMET-regu-
lating miRNAs. The method described here should be useful for
accomplishing this goal.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
Breast cancer cell lines were obtained from American Type Culture Collection
and cultured as recommended. Unless otherwise stated, DharmaFECT 1
reagent (Dharmacon) was used for transfection. Control miRNA (cel-miR-67)
or miR-522 mimic (50 nM, Thermo Scientific) was used to transfect 100,000
cells/well in suspension in 12-well dishes as per manufacturer’s protocol,
and medium was changed after 24 hr.
Microarray
Total RNA, extracted using Trizol (Invitrogen) 48 hr after transfection from
biological triplicate wells, was purified with the RNeasy kit (QIAGEN). cDNA
and cRNA were generated and hybridized to HT-12 v4 beadchips (Illumina)
according to the manufacturer’s protocols. Cubic spline-normalized (without
background normalization) data were analyzed by the NIA Array Analysis
tool (http://lgsun.grc.nia.nih.gov/ANOVA) to identify transcripts downregu-
lated after miR-522 overexpression.
Pulldown-Seq
MDA-MB-468 pull-down experiments with control miRNA (cel-miR-67) and
miR-522 mimic (Thermo Scientific) were conducted as described previously
but modified to include molecular crowders in the lysis buffer (Lal et al.,
2011; Tan et al., 2014). Briefly, cell pellets were collected 24 hr posttransfec-
tion, washed twice with cold PBS, and incubated with lysis buffer (20 mM Tris
[pH 7], 25mM EDTA [pH 8], 100 mM KCl, 5 mM MgCl2 [all Ambion], 2.5 mg/ml
Ficoll PM400, 7.5 mg/ml Ficoll PM70 [GE Healthcare], 0.25 mg/ml dextran
sulfate 670k, 0.3% NP-40 [Fluka], 50 U each of RNase OUT and SUPERase
In [Invitrogen], and complete protease inhibitor cocktail [Roche Applied Sci-Cell Reports 8, 12ence]) on ice for 20 min. The cytoplasmic lysate, isolated
by centrifugation at 5,000 g for 5 min, was added to 1 mg/
ml yeast tRNA and 1 mg/ml BSA (Ambion)-blocked streptavi-
din (SA)-coated magnetic beads (Invitrogen) and rotated for
4 hr at 4C. The beads were washed five times with 1 ml lysis
buffer and bead-bound RNA extracted using Trizol LS (Invi-
trogen). Ribosomal RNA was depleted using the Ribo-Zero
rRNA removal kit (Epicenter). Libraries were generated using
the NEBNext Multiplex Small RNA Library Prep Set with
modified adaptors and primers compatible for Ion Torrent
Sequencing Platform (New England Biolabs) and sequenced
on the Ion Torrent platform using the 314 Chip (Invitrogen),
according to the manufacturer’s protocols.
IMPACT-Seq
The IMPACT-seq protocol used the Pulldown-seq protocol to
isolate miRNA-boundRNAswith SA beads as above. The cyto-plasmic lysate-SA bead mixture was incubated with rotation overnight at 4C
before adding RNase T1 (25 U/ml) for 10 min on-bead digestion at 37C. RNA
was then extracted from washed beads using Trizol LS as above. The RNA
was treated with T4 Polynucleotide Kinase (NEB) to obtain 50-phosphate ends
for subsequent ligations and then passed through NucAway columns (Ambion)
to remove RNAs <20 nt in length. Libraries were generated using the NEBNext
Small RNA Sample Prep Set for Illumina chemistry (NEB). cDNA fragments with
an insert size of 20–60 nt were gel extracted and sequenced on the HiSeq plat-
form (Illumina) according to the manufacturer’s protocol.
RNA-Seq Quality Control and Alignment
Prealignment and postalignment libraries were screened for quality, speci-
ficity of mapping, and contaminant sequences using FASTQC (http://www.
bioinformatics.babraham.ac.uk/projects/fastqc/), RSeQC (Wang et al.,
2012), and RNA-SeQC (DeLuca et al., 2012). Prior to alignment, low-quality
bases, homopolymer sequences, sequences matching the first 13 bp, and
the reverse complement of the adaptor sequences for IonTorrent or Illumina
were trimmed using cutadapt version 1.2.1 (Martin, 2011). Trimmed reads
smaller than 30 nt for Pulldown-seq or 20 nt for IMPACT-seq were discarded.
Pulldown-seq used reads that uniquely mapped to the GRCh37 assembly of
the human genome augmented with the Ensembl 68 genome annotation using
Novoalign (http://www.novocraft.com) with the following parameters: -H -k -n
250 -F STDFQ -r all 10 -e 10 -g 15 -x 4. IMPACT-seq used reads that uniquely
mapped (with greater than or equal to twomismatches) to the GRCh37 assem-
bly of the human genome augmented with the Ensembl 72 genome annotation
(Flicek et al., 2013), using Tophat version 2.0.8b (Trapnell et al., 2009). Quality
control, trimming, and alignment were performed using the bipy (https://
github.com/roryk/bipy) and bcbio-nextgen (https://github.com/chapmanb/
bcbio-nextgen) automated sequencing analysis pipelines.
Pulldown-Seq Target Identification
Postalignment gene counts were generated using htseq-count 0.5.4p3 with
the counts aggregated by gene_id of the Ensembl 68 annotation. Differentially
expressed transcripts were called with DESeq version 1.9.2 using the default
options (Anders and Huber, 2010). The top hits with FE > 2 and p < 0.05 were
flagged as candidates for downstream biological verification.
IMPACT-Seq MRE Identification
Peaks were called on both control miRNA and miR-522 IMPACT-seq samples
using CLIPper (https://github.com/YeoLab/clipper/) with the following25–1239, August 21, 2014 ª2014 The Authors 1237
parameters: –poisson-cutoff = 0.05–superlocal–max_gap = 0–processors = 8
-b $file -s hg19 -o $file. MREs were identified by requiring that the peak have
greater than or equal to five reads in the miR-522 sample with at least twice as
many normalized reads in the miR-522 sample as control.
Target Functional Analysis
We first identified possible common transcription-factor-binding sites in all
miR-522 target genes identified by Pulldown-seq with TRANSFAC (http://
www.gene-regulation.com), using the default settings. We then used IPA
(http://www.ingenuity.com) to connect all miR-522 target genes that were
directly related with the default settings, as defined by the curated IPA data-
base, without selecting the optional predicted miRNA interactions. This list
of genes was then subject to a core analysis with the default IPA settings, to
generate a list of IPA scores for the top associated network functions and
significantly enriched molecular functions. We then performed a similar IPA
core analysis on directly related genes that were significantly downregulated
after miR-522 overexpression. A list of the significantly enriched molecular
functions shared by the Pulldown-seq and downregulated gene interactomes
was used to identify common functions.
Statistical Analysis
In vitro data were analyzed using unpaired Student’s t test; cumulative distri-
bution plots were analyzed using the Kolmogorov-Smirnov test (K-S test).
p < 0.05 was considered significant. *p < 0.05; **p < 0.01; ***p < 0.001. The
mean ± SD of three or more independent experiments is reported.
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Pull-down, IMPACT RNA-seq, and overexpression microarray datasets are
available in the ArrayExpress database (http://www.ebi.ac.uk/arrayexpress)
under accession numbers E-MTAB-2112, E-MTAB-2119, and E-MTAB-
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